Skip to main content
VREX logo

Varex Imaging Corporation (VREX) Stock Price & Analysis

Varex Imaging Corporation (VREX) — MoonshotScore 62/100 (Fair band), calculated Nov 18, 2026. Price $18.10 (-0.22%), as of the Nov 20, 2026 trading session; market cap $769M.

Educational signal · not a buy or sell recommendation · How to read this

$18.10 −$0.04 (-0.22%) Market Cap $769M

Varex Imaging Corporation · VREX · NASDAQ

Varex Imaging Corporation designs and manufactures X-ray imaging components for medical and industrial applications. The company operates globally, serving original equipment manufacturers, service companies, and end-users.

Price as of Nov 20, 2026

Key Statistics

62 of 100

MoonshotScore v2 · Varex Imaging (VREX)

Fair
Business Quality Solid (74)
Financial Safety Strained (32)
Valuation Fair (70)
Growth Durability Flat (51)
Momentum Surging (94)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality, but a strained balance sheet; the market is already moving on it. The score also carries a risk penalty for reported profit not backed by cash flow. Business Quality: Solid; Financial Safety: Strained; Valuation: Fair; Growth Durability: Flat; Momentum: Surging.

  • EPS beat 1 of the last 4 reports
  • Altman Z 2.26 · Piotroski F 6
  • ROE 4.6% · ROA 4.2% · current ratio 3.38

Holding back: balance-sheet strain

Helping: business quality, an attractive price, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for VREX (58 recorded, newest six shown)
RecordedScoreBand
58Fair
58Fair
58Fair
62Fair
62Fair
62Fair

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$18.10
Change on the day-0.22%
Market capitalisation$769M
Price / earnings (trailing)34.48
Shares traded on the day620.4K

Price & events

Other perspectives

Council score for Varex Imaging (VREX): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Weak
Valuation Moderate
Growth Durability Neutral
Momentum Strong

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Neutral read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Weak
Debt/Equity Weak
ROE Weak
Gross Margin Neutral

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Varex Imaging (VREX), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Varex Imaging Corporation (VREX) is listed on NASDAQ. It employs 2,500 people. The market values it at $769M.

2 · Latest results

What do the latest results show for Varex Imaging (VREX)?

Short answer · as of

Against analyst estimates the company has EPS beat 1 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Jun 2025$203M-$89M-$2.15 (diluted)
Sep 2025$229M$12M$0.29 (diluted)
Dec 2025$210M$2M$0.05 (diluted)
Mar 2026$216M-$8M-$0.19 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Varex Imaging (VREX)?

Short answer

The MoonshotScore pillars rate business quality, an attractive price, positive momentum as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z 2.26 · Piotroski F 6. Trailing ratios: ROE 4.6% · ROA 4.2% · current ratio 3.38.

4 · What to check next?

What should you watch next at Varex Imaging (VREX)?

Short answer · as of

Analyst estimates on file carry FY2026 revenue $865.90M · EPS 0.84 · 2 analysts. The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Varex Imaging compare with its peers?

Short answer

Varex Imaging's score ranks 8th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Delcath Systems, Inc. (DCTH) Same industry, near in market value$18.79 Nov 20, 2026$654M94 5-pillar Nov 18, 2026
IRadimed Corporation (IRMD) Same industry, near in market value$81.02 Nov 20, 2026$1.04B94 5-pillar Nov 18, 2026
InMode Ltd. (INMD) Same industry, near in market value$12.42 Nov 20, 2026$715M92 5-pillar Nov 18, 2026
Tactile Systems Technology, Inc. (TCMD) Same industry, near in market value$25.60 Nov 20, 2026$573M90 5-pillar Nov 18, 2026
Bioventus Inc. (BVS) Same industry, near in market value$9.95 Nov 19, 2026$681M79 5-pillar Nov 18, 2026
CONMED Corporation (CNMD) Same industry, near in market value$46.56 Nov 20, 2026$1.39B79 5-pillar Nov 18, 2026
Integra LifeSciences Holdings Corporation (IART) Same industry, near in market value$13.25 Nov 20, 2026$1.03B68 5-pillar Nov 18, 2026
Varex Imaging (VREX) — this page$18.10$769M62
SI-BONE, Inc. (SIBN) Same industry, near in market value$23.73 Nov 20, 2026$1.07B39 5-pillar Nov 18, 2026
OrthoPediatrics Corp. (KIDS) Same industry, near in market value$31.74 Nov 20, 2026$829M37 5-pillar Nov 18, 2026
Artivion Inc. (AORT) Same industry, near in market value$18.16 Nov 20, 2026$886M34 5-pillar Nov 18, 2026
Sight Sciences, Inc. (SGHT) Same industry, near in market value$10.18 Nov 20, 2026$566M34 5-pillar Nov 18, 2026
Cytek Biosciences, Inc. (CTKB) Same industry, near in market value$6.12 Nov 20, 2026$800M33 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$14.50 – $14.50
Last captured analyst target (expired, captured Nov 18, 2026)
$14.50
Last captured median analyst target (expired, captured Nov 18, 2026)
$14.50
Revenue estimate
$865.90M
EPS estimate
$0.84

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 12, 2026

Transactions
8
Identified insiders
4
Purchases
0
Sales
2
Other transactions
6

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held VREX in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported VREX in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Varex Imaging (VREX)?

Read these with our analysis →

Varex Imaging Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the VREX research dossier (written May 6, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for VREX?

VREX carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Varex Imaging Corporation designs and manufactures X-ray imaging components for medical and industrial applications.

Is VREX a good stock to buy?

Stock Expert AI does not rate VREX buy, sell or hold. Varex Imaging Corporation carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the VREX stock price today?

The last price recorded for Varex Imaging Corporation (VREX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the VREX price target?

The last analyst consensus price target we captured for Varex Imaging Corporation (VREX), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What are the main risks for VREX?

The main risks for Varex Imaging Corporation include intense competition in the X-ray imaging market, which could pressure pricing and market share. Economic downturns may reduce healthcare and industrial spending, impacting demand for Varex's products.

What are the key factors to evaluate for VREX?

Varex Imaging Corporation (VREX) holds a MoonshotScore in the moderate range. To weigh it, start with the trailing P/E under Price & valuation on this page. Operates in two segments: Medical and Industrial, diversifying its revenue streams. Not financial advice.

How frequently does VREX data refresh on this page?

VREX's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven VREX's recent stock price performance?

Varex Imaging Corporation (VREX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive product portfolio in X-ray imaging components. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider VREX overvalued or undervalued right now?

The trailing P/E of Varex Imaging Corporation (VREX) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 6, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 12 from Financial Modeling Prep (FMP), 5 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.